Updated Results From Destiny-Breast01, A Phase 2 Trial Of Trastuzumab Deruxtecan (T-Dxd) In Her2 Positive Metastatic Breast Cancer
CANCER RESEARCH(2021)
Key words
positive metastatic destiny-breast01 cancer,destiny-breast01 cancer,trastuzumab,t-dxd
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined